Addition/Correction pubs.acs.org/jmc
Correction to Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor through Virtual Screening Nathan A. Lack, Peter Axerio-Cilies, Peyman Tavassoli, Frank Q. Han, Ka Hong Chan, Clementine Feau, Eric LeBlanc, Emma Tomlinson Guns, R. Kiplin Guy, Paul S. Rennie, and Artem Cherkasov* Journal of Medicinal Chemistry 2011, 54, 8563−8573. DOI: 10.1021/jm201098n Page 8563. The following additional affiliation should be associated with author Nathan A. Lack: School of Medicine, Koç University, Sariyer, Istanbul, Turkey, 34450. Page 8572: The Acknowledgments should be the following: This work was supported by a Proof-of Principle CIHR grant, Genome British Columbia Strategic Opportunities Program, and the PC-STAR Project, which is funded by Prostate Cancer Canada with the support of Safeway. The authors thank Dr. Maia Vinogradova for her assistance in crystallographic experiments and Hong Zheng and Eleanore Hendrickson of Structure-Based Design for their valuable contributions. The determination of the structures of the BF3 binders with the AR has been done by the Structure-Based Design Company (www.strbd.com) as a contract research. We are also grateful to the staff at the Lawrence Berkeley National Laboratory for assistance with X-ray data collection, and we thank Hans Adomat for his considerable assistance conducting the LC/MS analysis. Page 8573. Reference 37 should be as follows: Feau, C.; Arnold, L. A.; Kosinski, A.; Guy, R. K. A highthroughput ligand competition binding assay for the androgen receptor and other nuclear receptors. J. Biomol. Screening 2009, 14, 43−48.
Published: December 28, 2011 565
dx.doi.org/10.1021/jm201689y | J. Med. Chem. 2012, 55, 565−565
